Conestat Alfa
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Conestat Alfa, covering 2024-11-07 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation [Phase 2]